– FDA Advisory Committee voted to recommend easing compounding restrictions for six peptides, including Epitalon and Semax, late last week –   – These two peptides have attracted growing scientific interest for their potential neuroprotective and cognitive-supportive properties – – Collaboration represents a significant step toward making precision cognitive care more measurable, scalable, and clinically actionable –   KENMORE, N.Y. and LOS ANGELES, July 28, 2026 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company advancing precision neuroscience, and Next Health, a global leader in health optimization and longevity, today announced a strategic partnership to launch a novel precision cognitive health platform integrating Firefly’s AI-powered, U.S. Food...

Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder (“AUD”), addiction, and weight management, recently announced the successful completion of treatment for all participants in Part A of its ongoing Phase I/II clinical trial evaluating CMND-100 for the treatment of AUD. All 24 participants across cohorts 1 through 4 have successfully completed treatment according to the study protocol. The Company is currently assessing the dataset and, assuming results remain favorable, intends to initiate the next stage of the clinical program in AUD patients. “We are pleased to have successfully completed treatment for all participants in Part...

Correction: the company name has been corrected. On 28 July, international terminal operator AB KN Energies (hereinafter – the Company, KNE) and Vietnam-based INDEL Investment and Development Joint Stock Company (hereinafter – Indel Petro) signed a Memorandum of Understanding (MoU) in Vietnam to establish a framework for cooperation in energy and infrastructure projects in the country. The agreement brings together KNE’s international experience in LNG and energy infrastructure with Indel Petro’s activities across the petroleum, energy, logistics and infrastructure sectors in Vietnam. Operating LNG infrastructures since 2014, KN Energies has developed a strong international footprint, providing LNG terminal development, commercial and technical advisory, and FSRU-related expertise across Europe, South America and Asia. Through this partnership,...

LONDON, July 28, 2026 (GLOBE NEWSWIRE) — Traveling with a baby changes how families choose a holiday. According to new KAYAK search data, French parents planning summer 2026 trips with a child under two are largely opting for sun, sea and shorter journeys, with most of the top-searched destinations within about three hours of France. Mediterranean destinations dominate the ranking, with Spain, Portugal, Morocco and Tunisia all featuring strongly. The appeal is clear: shorter flight times, mild weather and easy-to-navigate cities can make traveling with a baby feel far more manageable. In fact, nine of the 10 most-searched destinations are within around a three-hour flight. For parents traveling with young children, every extra hour in the air can mean more disrupted naps, feedings and in-flight stress, making nearby destinations...

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (Nasdaq: DCX) (“DCX” or the “Company”), a digital asset treasury management company, today announced that DexTrader, the on-chain data platform of the Company , has completed comprehensive product and strategic upgrades. The overhaul includes reconstruction of underlying data architecture, expansion of omnichain data capabilities and optimization of user service frameworks. Concurrently, the platform announced its revised strategic focus: it intends to target the niche market of digital asset information and data services for token-based derivatives, yield instruments and collateralized assets. By pre-emptively building industry data infrastructure, DexTrader hopes to establish a solid foundation for product iteration and market leadership in the future. As...

–Technology Transfer Agreement for Regenerative Medicine Late-Stage Development Program– –Two Additional Agreements Supporting Early-Stage Programs Including Formulation and Development for a Global Medical Technology Company — — All Programs are Additive to Lifecore’s High-Value Pipeline and Expected to Contribute to 2028 Revenue — CHASKA, Minn., July 28, 2026 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced it has signed three new customer agreements, further expanding its pipeline of early- and late-stage programs. The three agreements span multiple therapeutic and technology areas, demonstrating the breadth of Lifecore’s technical capabilities and its...